Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Unlock Free Earnings Estimates
Shengxiang Biology: Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024
Oct 23 12:00 ET
Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024
Full text of Sansure Biotech Inc.'s 2024 interim report
Aug 18 12:00 ET
Summary of Sansure Biotech Inc.'s 2024 half-yearly report.
Read more
See the daily top gainer.
Updated: Dec 23, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data